The objective of this retrospective case series is to describe the clinical features of patients with primary glioblastoma multiforme and to identify the presence of the MGMT protein in the tissue. Seventeen patients were selected. Tissue samples were analyzed by the neuropathologist to confirm GBM diagnosis.
